Ramsey Hachem

Research output

Research output per year 2004 2018 2019 2020 2021 2022 2023 2023

• 144 Article
• 17 Review article
• 6 Editorial
• 4 Chapter
• 4 More
  • 2 Comment/debate
  • 2 Letter

Research output per year

Research output per year

Search results

• 2023

  Antibody-Mediated Rejection: Diagnosis and Treatment

  Halverson, L. P. & Hachem, R. R., Mar 2023, In: Clinics in Chest Medicine. 44, 1, p. 95-103 9 p.

  Research output: Contribution to journal › Review article › peer-review

• Anti-fibrotic therapy and lung transplant outcomes in patients with idiopathic pulmonary fibrosis

  Astor, T. L., Goldberg, H. J., Snyder, L. D., Courtwright, A., Hachem, R., Pena, T., Zaffiri, L., Criner, G. J., Budev, M. M., Thaniyavarn, T., Leonard, T. B., Bender, S., Barakat, A., Breeze, J. L. & LaCamera, P., Jan 1 2023, In: Therapeutic Advances in Respiratory Disease. 17

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Idiopathic Pulmonary Fibrosis 100%
  • Transplants 51%
  • Lung 44%
  • nintedanib 39%
  • pirfenidone 38%

• Characteristics of donor lungs declined on site and impact of lung allocation policy change

  Terada, Y., Takahashi, T., Hachem, R. R., Lu, E., Witt, C. A., Byers, D. E., Guillamet, R. V., Kulkarni, H. S., Nava, R. G., Kozower, B. D., Meyers, B. F., Pasque, M. K., Patterson, G. A., Marklin, G. F., Eghtesady, P., Kreisel, D. & Puri, V., 2023, (Accepted/In press) In: Journal of Thoracic and Cardiovascular Surgery.

  Research output: Contribution to journal › Article › peer-review

  • Lung 100%
  • Odds Ratio 53%
  • Tissue and Organ Procurement 50%
  • Confidence Intervals 49%
  • Transplants 38%
  1 Scopus citations

• Clinical recommendations for posttransplant assessment of anti–HLA (Human Leukocyte Antigen) donor-specific antibodies: A Sensitization in Transplantation: Assessment of Risk consensus document

  STAR 2022 Working Group, Jan 2023, In: American Journal of Transplantation. 23, 1, p. 115-132 18 p.

  Research output: Contribution to journal › Article › peer-review

  • HLA Antigens 100%
  • Risk Assessment 81%
  • Transplantation 74%
  • Antibodies 53%
  • Patient Care Management 17%
  6 Scopus citations

• Defining a natural killer cell-enriched molecular rejection-like state in lung transplant transbronchial biopsies

  Gauthier, P. T., Mackova, M., Hirji, A., Weinkauf, J., Timofte, I. L., Snell, G. I., Westall, G. P., Havlin, J., Lischke, R., Zajacová, A., Simonek, J., Hachem, R., Kreisel, D., Levine, D., Kubisa, B., Piotrowska, M., Juvet, S., Keshavjee, S., Jaksch, P., Klepetko, W., & 2 othersHalloran, K. & Halloran, P. F., 2023, (Accepted/In press) In: American Journal of Transplantation.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Natural Killer Cells 100%
  • Transplants 67%
  • T-Lymphocytes 66%
  • Biopsy 65%
  • Lung 57%

• Developing machine learning models to predict primary graft dysfunction after lung transplantation

  Michelson, A., Oh, I., Gupta, A., Puri, V., Kreisel, D., Gelman, A. E., Nava, R., Witt, C., Byers, D., Halverson, L., Vazquez-Guillamet, R., Payne, P. R. O. & Hachem, R., 2023, (Accepted/In press) In: American Journal of Transplantation.

  Research output: Contribution to journal › Article › peer-review

  • Primary Graft Dysfunction 100%
  • Lung Transplantation 73%
  • Machine Learning 71%
  • Calibration 10%
  • ROC Curve 8%

• Development and validation of the lung donor (LUNDON) acceptability score for pulmonary transplantation

  Heiden, B. T., Yang, Z., Bai, Y. Z., Yan, Y., Chang, S. H., Park, Y., Colditz, G. A., Dart, H., Hachem, R. R., Witt, C. A., Vazquez Guillamet, R., Byers, D. E., Marklin, G. F., Pasque, M. K., Kreisel, D., Nava, R. G., Meyers, B. F., Kozower, B. D. & Puri, V., Apr 2023, In: American Journal of Transplantation. 23, 4, p. 540-548 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Lung Transplantation 100%
  • Tissue Donors 67%
  • Lung 46%
  • Brain Death 19%
  • Oxygen 11%

• Impact of pre-lung transplant statin use on the development of primary graft dysfunction

  Yuenger, V., January, S., Fester, K., McCloskey, M. & Hachem, R., Mar 2023, In: Pharmacotherapy. 43, 3, p. 189-195 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Primary Graft Dysfunction 100%
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors 61%
  • Transplants 39%
  • Lung 33%
  • Lung Transplantation 22%
  1 Scopus citations

• Outcomes of Extracorporeal Membrane Oxygenation for Primary Graft Dysfunction After Lung Transplantation

  Takahashi, T., Terada, Y., Pasque, M. K., Nava, R. G., Kozower, B. D., Meyers, B. F., Patterson, G. A., Kreisel, D., Puri, V. & Hachem, R. R., May 2023, In: Annals of Thoracic Surgery. 115, 5, p. 1273-1280 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Primary Graft Dysfunction 100%
  • Extracorporeal Membrane Oxygenation 74%
  • Lung Transplantation 73%
  • Membranes 5%
  • Survival 5%
  2 Scopus citations

• Point-Counterpoint: Desensitization to improve the likelihood of lung transplantation

  Roux, A. & Hachem, R. R., Jan 2023, In: Human Immunology. 84, 1, p. 43-45 3 p.

  Research output: Contribution to journal › Letter › peer-review

• Position paper: Models of post-transplant care for individuals with cystic fibrosis

  McKone, E., Ramos, K. J., Chaparro, C., Blatter, J., Hachem, R., Anstead, M., Vlahos, F., Thaxton, A., Hempstead, S., Daniels, T., Murray, M., Sole, A., Vos, R., Tallarico, E., Faro, A. & Pilewski, J. M., May 2023, In: Journal of Cystic Fibrosis. 22, 3, p. 374-380 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Cystic Fibrosis 100%
  • Transplants 64%
  • Lung 27%
  • Communication 15%
  • Consensus 9%
  1 Scopus citations

• Potential Role of Computed Tomography Volumetry in Size Matching in Lung Transplantation

  Vazquez Guillamet, R., Rjob, A., Bierhals, A., Tague, L., Marklin, G., Halverson, L., Witt, C., Byers, D., Hachem, R., Gierada, D., Brody, S. L., Takahashi, T., Nava, R., Kreisel, D., Puri, V. & Trulock, E., Mar 2023, In: Transplantation Proceedings. 55, 2, p. 432-439 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Lung Transplantation 100%
  • Total Lung Capacity 64%
  • Primary Graft Dysfunction 60%
  • Tomography 58%
  • Cone-Beam Computed Tomography 53%

• Pulmonary Carcinoid Tumorlet in the Explanted Lungs for Lung Transplantation: A Case Series of 15 Patients

  Terada, Y., Hachem, R. R., Pasque, M. K., Kulkarni, H. S., Witt, C. A., Byers, D. E., Guillamet, R. V., Nava, R. G., Kozower, B. D., Meyers, B. F., Patterson, G. A., Kreisel, D., Puri, V. & Takahashi, T., Mar 2023, In: Transplantation Proceedings. 55, 2, p. 446-448 3 p.

  Research output: Contribution to journal › Article › peer-review

  • Lung Transplantation 100%
  • Carcinoid Tumor 97%
  • Lung 46%
  • Lung Diseases 21%
  • Chronic Obstructive Pulmonary Disease 13%

• Tocilizumab for antibody-mediated rejection treatment in lung transplantation

  January, S. E., Fester, K. A., Halverson, L. P., Witt, C., Byers, D., Vazquez-Guillamet, R., Alexander-Brett, J., Tague, L. K., Kreisel, D., Gelman, A., Puri, V., Bahena, R. N., Takahashi, T., Hachem, R. & Kulkarni, H. S., 2023, (Accepted/In press) In: Journal of Heart and Lung Transplantation.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • tocilizumab 100%
  • Lung Transplantation 82%
  • Antibodies 39%
  • Tissue Donors 22%
  • Transplant Recipients 13%

• Utilizing computed tomography volumetry for size matching prior to lung transplantation: a case series

  Shepherd, H. M., Farahnak, K., Harrison, M. S., Frye, C. C., Marklin, G. F., Bierhals, A. J., Hachem, R. R., Witt, C. A., Guillamet, R. V., Byers, D. E., Kozower, B. D., Meyers, B. F., Nava, R. G., Patterson, G. A., Kreisel, D. & Puri, V., Apr 2023, In: Journal of Thoracic Disease. 15, 4, p. 2233-2239 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Lung Transplantation 100%
  • Tissue Donors 67%
  • Tomography 58%
  • Lung 46%
  • Decision Making 28%
• 2022

  A comparison of outcomes after lung transplantation between European and North American centers

  Yang, Z., Takahashi, T., Terada, Y., Meyers, B. F., Kozower, B. D., Patterson, G. A., Nava, R. G., Hachem, R. R., Witt, C. A., Byers, D. E., Kulkarni, H. S., Guillamet, R. V., Yan, Y., Chang, S. H., Kreisel, D. & Puri, V., Dec 2022, In: Journal of Heart and Lung Transplantation. 41, 12, p. 1729-1735 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Lung Transplantation 100%
  • North America 68%
  • Survival 47%
  • Universal Health Care 31%
  • Heart-Lung Transplantation 30%
  1 Scopus citations

• Acute Interstitial Pneumonia (Hamman–Rich Syndrome) in Lung Transplantation: A Case Series

  Shepherd, H. M., Terada, Y., Takahashi, T., Pasque, M. K., Kulkarni, H. S., Guillamet, R. V., Witt, C. A., Nava, R. G., Puri, V., Kreisel, D., Patterson, G. A. & Hachem, R. R., Oct 2022, In: Transplantation Proceedings. 54, 8, p. 2313-2316 4 p.

  Research output: Contribution to journal › Article › peer-review

  • Hamman-Rich Syndrome 100%
  • Lung Transplantation 72%
  • Artificial Respiration 16%
  • Primary Graft Dysfunction 14%
  • Extracorporeal Membrane Oxygenation 10%
  1 Scopus citations

• A pilot randomized controlled trial of de novo belatacept-based immunosuppression following anti-thymocyte globulin induction in lung transplantation

  Huang, H. J., Schechtman, K., Askar, M., Bernadt, C., Mittler, B., Dore, P., Witt, C., Byers, D., Vazquez-Guillamet, R., Halverson, L., Nava, R., Puri, V., Gelman, A., Kreisel, D. & Hachem, R. R., Jul 2022, In: American Journal of Transplantation. 22, 7, p. 1884-1892 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Abatacept 100%
  • Antilymphocyte Serum 88%
  • Lung Transplantation 82%
  • Immunosuppression 64%
  • Randomized Controlled Trials 47%
  7 Scopus citations

• Bleeding and thrombotic complications associated with anticoagulation prior to lung transplantation: a case series

  Shepherd, H. M., Hachem, R. R., Witt, C. A., Guillamet, R. V., Byers, D. E., Kozower, B. D., Meyers, B. F., Takahashi, T., Alexander Patterson, G., Puri, V., Kreisel, D. & Nava, R. G., Aug 2022, In: Journal of Thoracic Disease. 14, 8, p. 2917-2926 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Lung Transplantation 100%
  • Hemorrhage 55%
  • International Normalized Ratio 39%
  • Chest Tubes 21%
  • Venous Thromboembolism 18%

• Clinical features and outcomes of unplanned single lung transplants

  Terada, Y., Takahashi, T., Hachem, R. R., Liu, J., Witt, C. A., Byers, D. E., Guillamet, R. V., Kulkarni, H. S., Nava, R. G., Kozower, B. D., Meyers, B. F., Pasque, M. K., Patterson, G. A., Kreisel, D. & Puri, V., Dec 2022, In: Journal of Thoracic and Cardiovascular Surgery. 164, 6, p. 1650-1659.e3

  Research output: Contribution to journal › Article › peer-review

  • Transplants 100%
  • Lung 85%
  • Idiopathic Pulmonary Fibrosis 21%
  • Chronic Obstructive Pulmonary Disease 15%
  • Tissue Donors 13%
  1 Scopus citations

• Coronavirus Disease 2019 Positivity Immediately After Lung Transplantation: A Case Report

  Yokoyama, Y., Terada, Y., Nava, R. G., Puri, V., Kreisel, D., Patterson, G. A., Hachem, R. R. & Takahashi, T., Jul 1 2022, In: Transplantation Proceedings. 54, 6, p. 1572-1574 3 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Coronavirus 100%
  • Lung Transplantation 92%
  • GS-5734 84%
  • Basiliximab 59%
  • Tacrolimus 42%
  1 Scopus citations

• Lung Allograft Rejection

  Levine, D. J. & Hachem, R. R., May 1 2022, In: Thoracic surgery clinics. 32, 2, p. 221-229 9 p.

  Research output: Contribution to journal › Review article › peer-review

  • Allografts 100%
  • Antibodies 63%
  • Lung 61%
  • Lung Transplantation 44%
  • Transplantation 29%
  1 Scopus citations

• Lung Transplant for Pulmonary Fibrosis With Dendriform Ossification

  Terada, Y., Puri, V., Meyers, B. F., Kreisel, D., Patterson, G. A., Hachem, R. R. & Takahashi, T., Dec 2022, In: Annals of Thoracic Surgery. 114, 6, p. e403-e405

  Research output: Contribution to journal › Article › peer-review

  • Pulmonary Fibrosis 100%
  • Osteogenesis 76%
  • Transplants 54%
  • Lung 46%
  • Idiopathic Pulmonary Fibrosis 17%
  1 Scopus citations

• Novel role for tumor suppressor gene, liver kinase B1, in epithelial–mesenchymal transition leading to chronic lung allograft dysfunction

  Rahman, M., Ravichandran, R., Bansal, S., Sanborn, K., Bowen, S., Eschbacher, J., Sureshbabu, A., Fleming, T., Bharat, A., Walia, R., Hachem, R., Bremner, R. M., Smith, M. A. & Mohanakumar, T., Mar 2022, In: American Journal of Transplantation. 22, 3, p. 843-852 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Tumor Suppressor Genes 100%
  • Allografts 88%
  • Bronchiolitis Obliterans 79%
  • Phosphotransferases 78%
  • Exosomes 68%
  4 Scopus citations

• One-Year Survival Worse for Lung Retransplants Relative to Primary Lung Transplants

  Randhawa, S. K., Yang, Z., Morkan, D. B., Yan, Chang, S-H., Hachem, R. R., Witt, C., Byers, D. E., Kulkarni, H. S., Guillamet, R. V., Kozower, B. D., Nava, R. G., Meyers, B., Patterson, G. A., Kreisel, D. & Puri, V., Apr 2022, In: Annals of Thoracic Surgery. 113, 4, p. 1265-1273 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Transplants 100%
  • Survival 88%
  • Lung 85%
  • Lung Transplantation 71%
  • Confidence Intervals 14%
  3 Scopus citations

• Reprogramming alveolar macrophage responses to TGF-β reveals CCR2⁺ monocyte activity that promotes bronchiolitis obliterans syndrome

  Liu, Z., Liao, F., Zhu, J., Zhou, D., Heo, G. S., Leuhmann, H. P., Scozzi, D., Parks, A., Hachem, R., Byers, D. E., Tague, L. K., Kulkarni, H. S., Cano, M., Wong, B., Li, W., Haung, H. J., Krupnick, A. S., Kreisel, D., Liu, Y. & Gelman, A. E., Oct 3 2022, In: Journal of Clinical Investigation. 132, 19, e159229.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Bronchiolitis Obliterans 100%
  • Alveolar Macrophages 80%
  • Monocytes 60%
  • Biological Availability 21%
  • Decorin 16%
  5 Scopus citations

• The Impact of Center Volume on Outcomes in Lung Transplantation

  Yang, Z., Subramanian, M. P., Yan, Y., Meyers, B., Kozower, B. D., Patterson, G. A., Nava, R. G., Hachem, R. R., Witt, C., Pasque, M. K., Byers, D. E., Kulkarni, H. S., Kreisel, D., Itoh, A. & Puri, V., Mar 2022, In: Annals of Thoracic Surgery. 113, 3, p. 911-917 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Lung Transplantation 100%
  • Survival 47%
  • Confidence Intervals 30%
  • Organ Transplantation 18%
  • Proportional Hazards Models 15%
  10 Scopus citations

• The molecular features of chronic lung allograft dysfunction in lung transplant airway mucosa

  Halloran, K., Mackova, M., Parkes, M. D., Hirji, A., Weinkauf, J., Timofte, I. L., Snell, G. I., Westall, G. P., Lischke, R., Zajacova, A., Havlin, J., Hachem, R., Kreisel, D., Levine, D., Kubisa, B., Piotrowska, M., Juvet, S., Keshavjee, S., Jaksch, P., Klepetko, W., & 1 othersHalloran, P. F., Dec 2022, In: Journal of Heart and Lung Transplantation. 41, 12, p. 1689-1699 11 p.

  Research output: Contribution to journal › Article › peer-review

  • Allografts 100%
  • Mucous Membrane 91%
  • Transplants 71%
  • Lung 61%
  • Biopsy 23%
  1 Scopus citations

• Transcripts associated with chronic lung allograft dysfunction in transbronchial biopsies of lung transplants

  Parkes, M. D., Halloran, K., Hirji, A., Pon, S., Weinkauf, J., Timofte, I. L., Snell, G. I., Westall, G. P., Havlin, J., Lischke, R., Zajacová, A., Hachem, R., Kreisel, D., Levine, D., Kubisa, B., Piotrowska, M., Juvet, S., Keshavjee, S., Jaksch, P., Klepetko, W., & 1 othersHalloran, P. F., Apr 2022, In: American Journal of Transplantation. 22, 4, p. 1054-1072 19 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Allografts 100%
  • Transplants 71%
  • Biopsy 69%
  • Lung 61%
  • Gene Expression 17%
  7 Scopus citations

• Transplantation of Donor Lung With Partial Anomalous Pulmonary Venous Return Using a Carrel Patch

  Shepherd, H. M., Bierhals, A. J., Hachem, R. R., Takahashi, T., Pasque, M. K., Patterson, G. A., Puri, V., Kreisel, D. & Nava, R. G., Oct 2022, In: Annals of Thoracic Surgery.

  Research output: Contribution to journal › Article › peer-review

  • Scimitar Syndrome 100%
  • Lung Transplantation 76%
  • Drainage 37%
  • Lung 35%
  • Venae Cavae 25%
  1 Scopus citations

• Uncertainty analysis of chest X-ray lung height measurements and size matching for lung transplantation

  Guillamet, R. V., Guillamet, M. C. V., Rjob, A., Bierhals, A., Bello, I., Abularach, A. J., Tague, L., Wallendorf, M., Marklin, G. F., Witt, C., Byers, D. E., Kreisel, D., Nava, R., Puri, V., Hachem, R. & Trulock, E. P., Apr 2022, In: Journal of Thoracic Disease. 14, 4, p. 1042-1051 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Lung Transplantation 100%
  • Uncertainty 79%
  • X-Rays 66%
  • Thorax 59%
  • Lung 46%
  2 Scopus citations

• Variability in azithromycin practices among lung transplant providers in the International Society for Heart and Lung Transplantation Community

  Kapnadak, S. G., Morrell, E. D., Wai, T. H., Goss, C. H., Shah, P. D., Merlo, C. A., Hachem, R. R. & Ramos, K. J., Jan 2022, In: Journal of Heart and Lung Transplantation. 41, 1, p. 20-23 4 p.

  Research output: Contribution to journal › Article › peer-review

  • Heart-Lung Transplantation 100%
  • Azithromycin 86%
  • Transplants 44%
  • Lung 38%
  • Allografts 37%
  1 Scopus citations
• 2021

  Acute Cellular Rejection

  Frye, C. C., Gauthier, J. M., Hachem, R. R. & Kreisel, D., Jan 1 2021, Encyclopedia of Respiratory Medicine, Second Edition. Elsevier, Vol. 5. p. 729-734 6 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

  • Transplants 100%
  • Lung Transplantation 61%
  • Immunosuppression 48%
  • Anti-Inflammatory Agents 39%
  • Pathology 33%

• Antibody-Mediated Rejection After Lung Transplantation

  Hachem, R. R., Jan 1 2021, Encyclopedia of Respiratory Medicine, Second Edition. Elsevier, Vol. 5. p. 735-740 6 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

  • Lung Transplantation 100%
  • Antibodies 47%
  • HLA Antigens 35%
  • Allografts 30%
  • Heart-Lung Transplantation 24%

• Antibody-Mediated Rejection and Lung Transplantation

  Halverson, L. P. & Hachem, R. R., Jun 1 2021, In: Seminars in Respiratory and Critical Care Medicine. 42, 3, p. 428-435 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Lung Transplantation 100%
  • Psychology Rejection 99%
  • Antibodies 47%
  • Lung 26%
  • Consensus 23%
  5 Scopus citations

• Bacterial products in donor airways prevent the induction of lung transplant tolerance

  Tanaka, S., Gauthier, J. M., Terada, Y., Takahashi, T., Li, W., Hashimoto, K., Higashikubo, R., Hachem, R. R., Bharat, A., Ritter, J. H., Nava, R. G., Puri, V., Krupnick, A. S., Gelman, A. E. & Kreisel, D., Jan 2021, In: American Journal of Transplantation. 21, 1, p. 353-361 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Toll-Like Receptor 2 100%
  • Transplants 86%
  • Lung 73%
  • Allografts 51%
  • Monocytes 32%
  8 Scopus citations

• Circulating exosomes induced by respiratory viral infections in lung transplant recipients activate cellular stress, innate immune pathways and epithelial to mesenchymal transition

  Bansal, S., Limaye, A. P., Lee, J., Fleming, T., Poulson, C., Omar, A., Hachem, R., Bharat, A., Bremner, R. M., Smith, M. A. & Mohanakumar, T., Dec 2021, In: Transplant Immunology. 69, 101480.

  Research output: Contribution to journal › Article › peer-review

  • Exosomes 100%
  • Epithelial-Mesenchymal Transition 88%
  • Respiratory Tract Infections 78%
  • Transplant Recipients 78%
  • Virus Diseases 62%
  3 Scopus citations

• Circulating mitochondrial DNA is an early indicator of severe illness and mortality from COVID-19

  Scozzi, D., Cano, M., Ma, L., Zhou, D., Zhu, J. H., O'Halloran, J. A., Goss, C., Rauseo, A. M., Liu, Z., Sahu, S. K., Peritore, V., Rocco, M., Ricci, A., Amodeo, R., Aimati, L., Ibrahim, M., Hachem, R., Kreisel, D., Mudd, P. A., Kulkarni, H. S., & 1 othersGelman, A. E., Feb 22 2021, In: JCI Insight. 6, 4, e143299.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Cell-Free Nucleic Acids 100%
  • Mitochondrial DNA 83%
  • Mortality 39%
  • Renal Replacement Therapy 20%
  • Intubation 17%
  85 Scopus citations

• Clinical Features and Outcomes of Combined Pulmonary Fibrosis and Emphysema After Lung Transplantation

  Takahashi, T., Terada, Y., Pasque, M. K., Liu, J., Byers, D. E., Witt, C. A., Nava, R. G., Puri, V., Kozower, B. D., Meyers, B. F., Kreisel, D., Patterson, G. A. & Hachem, R. R., Nov 2021, In: CHEST. 160, 5, p. 1743-1750 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Pulmonary Emphysema 100%
  • Lung Transplantation 88%
  • Pulmonary Fibrosis 88%
  • Idiopathic Pulmonary Fibrosis 42%
  • Primary Graft Dysfunction 18%
  10 Scopus citations

• Clinical Outcomes of Lung Transplants From Donors With Unexpected Pulmonary Embolism

  Terada, Y., Gauthier, J. M., Pasque, M. K., Takahashi, T., Liu, J., Nava, R. G., Hachem, R. R., Witt, C. A., Byers, D. E., Vazquez Guillamet, R., Kozower, B. D., Meyers, B. F., Aguilar, P. R., Kulkarni, H. S., Patterson, G. A., Kreisel, D. & Puri, V., Aug 2021, In: Annals of Thoracic Surgery. 112, 2, p. 387-394 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Pulmonary Embolism 100%
  • Tissue Donors 79%
  • Transplants 63%
  • Lung 54%
  • Allografts 16%
  4 Scopus citations

• Cystic fibrosis foundation consensus statements for the care of cystic fibrosis lung transplant recipients

  Shah, P., Lowery, E., Chaparro, C., Visner, G., Hempstead, S. E., Abraham, J., Bhakta, Z., Carroll, M., Christon, L., Danziger-Isakov, L., Diamond, J. M., Lease, E., Leonard, J., Litvin, M., Poole, R., Vlahos, F., Werchan, C., Murray, M. A., Tallarico, E., Faro, A., & 2 othersPilewski, J. M. & Hachem, R. R., Jul 2021, In: Journal of Heart and Lung Transplantation. 40, 7, p. 539-556 18 p.

  Research output: Contribution to journal › Editorial

  Open Access

  • Cystic Fibrosis 100%
  • Transplant Recipients 95%
  • Lung 54%
  • Transplants 32%
  • Comorbidity 24%
  10 Scopus citations

• Decline in Club Cell Secretory Proteins, Exosomes Induction and Immune Responses to Lung Self-Antigens, Kα1 Tubulin and Collagen V, Leading to Chronic Rejection after Human Lung Transplantation

  Itabashi, Y., Ravichandran, R., Bansal, S., Bharat, A., Hachem, R., Bremner, R., Smith, M. & Mohanakumar, T., Jun 1 2021, In: Transplantation. 105, 6, p. 1337-1346 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Exosomes 100%
  • Lung Transplantation 98%
  • Autoantigens 93%
  • Tubulin 91%
  • Bronchiolitis Obliterans 70%
  13 Scopus citations

• Different-team procurements: A potential solution for the unintended consequences of change in lung allocation policy

  Yang, Z., Gerull, W. D., Shepherd, H. M., Marklin, G. F., Takahashi, T., Meyers, B. F., Kozower, B. D., Patterson, G. A., Nava, R. G., Hachem, R. R., Witt, C. A., Byers, D. E., Vazquez Guillamet, R., Pasque, M. K., Yan, Y., Kreisel, D. & Puri, V., Sep 2021, In: American Journal of Transplantation. 21, 9, p. 3101-3111 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Primary Graft Dysfunction 100%
  • Tissue Donors 99%
  • Lung 84%
  • Graft Survival 66%
  • Transplantation 48%
  3 Scopus citations

• Donor management using a specialized donor care facility is associated with higher organ utilization from drug overdose donors

  Frye, C. C., Gauthier, J. M., Bery, A., Gerull, W. D., Morkan, D. B., Liu, J., Shea Harrison, M., Terada, Y., Van Zanden, J. E., Marklin, G. F., Pasque, M. K., Nava, R. G., Meyers, B. F., Patterson, A. G., Kozower, B. D., Hachem, R., Byers, D., Witt, C., Kulkarni, H., Kreisel, D., & 1 othersPuri, V., Mar 2021, In: Clinical Transplantation. 35, 3, e14178.

  Research output: Contribution to journal › Article › peer-review

  • Drug Overdose 100%
  • Tissue Donors 56%
  • Opioid Epidemic 8%
  • Brain Death 7%
  • Communication 4%
  5 Scopus citations

• Impact of Nighttime Lung Transplantation on Outcomes and Costs

  Yang, Z., Takahashi, T., Gerull, W. D., Hamilton, C., Subramanian, M. P., Liu, J., Meyers, B. F., Kozower, B. D., Patterson, G. A., Nava, R. G., Hachem, R. R., Witt, C. A., Aguilar, P. R., Pasque, M. K., Byers, D. E., Kulkarni, H. S., Kreisel, D. & Puri, V., Jul 2021, In: Annals of Thoracic Surgery. 112, 1, p. 206-213 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Lung Transplantation 100%
  • Transplantation 65%
  • Costs and Cost Analysis 53%
  • Bronchiolitis Obliterans 35%
  • Survival 33%
  4 Scopus citations

• Incidentally Detected Chronic Lymphocytic Leukemia in Hilar Lymph Nodes at the Time of Lung Transplantation: A Case Report

  Terada, Y., Harrison, M. S., Nava, R. G., Witt, C. A., Byers, D. E., Guillamet, R. V., Meyers, B. F., Pasque, M. K., Patterson, G. A., Kreisel, D., Puri, V., Hachem, R. R. & Takahashi, T., Oct 2021, In: Transplantation Proceedings. 53, 8, p. 2619-2621 3 p.

  Research output: Contribution to journal › Article › peer-review

  • Lung Transplantation 100%
  • B-Cell Chronic Lymphocytic Leukemia 91%
  • Lymph Nodes 61%
  • Pulmonary Fibrosis 33%
  • Graft Rejection 31%

• Local versus distant lung donor procurement does not influence short-term clinical outcomes

  Gerull, W. D., Yang, Z., Kreisel, D., Nava, R., Meyers, B. F., Patterson, G. A., Kozower, B. D., Hachem, R. R., Witt, C., Byers, D., Kulkarni, H., Guillamet, R. V., Marklin, G. & Puri, V., Oct 2021, In: Journal of Thoracic and Cardiovascular Surgery. 162, 4, p. 1284-1293.e4

  Research output: Contribution to journal › Article › peer-review

  • Tissue Donors 100%
  • Lung 68%
  • Transplants 57%
  • Costs and Cost Analysis 22%
  • Length of Stay 13%
  5 Scopus citations

• Lung protective ventilation based on donor size is associated with a lower risk of severe primary graft dysfunction after lung transplantation

  Tague, L. K., Bedair, B., Witt, C., Byers, D. E., Vazquez-Guillamet, R., Kulkarni, H., Alexander-Brett, J., Nava, R., Puri, V., Kreisel, D., Trulock, E. P., Gelman, A. & Hachem, R. R., Oct 2021, In: Journal of Heart and Lung Transplantation. 40, 10, p. 1212-1222 11 p.

  Research output: Contribution to journal › Article › peer-review

  • Primary Graft Dysfunction 100%
  • Lung Transplantation 73%
  • Ventilation 56%
  • Tissue Donors 49%
  • Total Lung Capacity 39%
  9 Scopus citations

• Management of chronic rejection after lung transplantation

  Bedair, B. & Hachem, R. R., Nov 2021, In: Journal of Thoracic Disease. 13, 11, p. 6645-6653 9 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Lung Transplantation 100%
  • Allografts 75%
  • Lung 41%
  • Bronchiolitis Obliterans 21%
  • Cyclosporine 14%
  5 Scopus citations
• 2020

  Circulating exosomes with lung self-antigens as a biomarker for chronic lung allograft dysfunction: A retrospective analysis

  Sharma, M., Gunasekaran, M., Ravichandran, R., Fisher, C. E., Limaye, A. P., Hu, C., McDyer, J., Kaza, V., Bharat, A., Tokman, S., Omar, A., Arjuna, A., Walia, R., Bremner, R. M., Smith, M. A., Hachem, R. R. & Mohanakumar, T., Nov 2020, In: Journal of Heart and Lung Transplantation. 39, 11, p. 1210-1219 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Bronchiolitis Obliterans 100%
  • Exosomes 85%
  • Autoantigens 80%
  • Allografts 63%
  • Biomarkers 47%
  20 Scopus citations